A phase 2 study of vorinostat in acute myeloid leukemia

BACKGROUND: This two-stage, multi-institutional, randomized phase 2 trial assessed the toxicity and response rate associated with two treatment schedules of the histone deacetylase inhibitor, vorinostat (suberoylanilide hydroxamic acid; SAHA) in patients with relapsed acute myeloid leukemia and in s...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Schaefer, Eric W., Loaiza-Bonilla, Arturo, Juckett, Mark, DiPersio, John F., Roy, Vivek, Slack, James, Wu, Wenting, Laumann, Kristina, Espinoza-Delgado, Igor, Gore, Steven D.
Formato: Artigo
Lenguaje:Inglês
Publicado: Ferrata Storti Foundation 2009
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2754953/
https://ncbi.nlm.nih.gov/pubmed/19794082
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2009.009217
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares